XML 56 R25.htm IDEA: XBRL DOCUMENT v3.23.1
FAIR VALUE MEASUREMENTS (Tables)
9 Months Ended
Mar. 31, 2023
Fair Value Disclosures [Abstract]  
Schedule of financial assets and liabilities measured at fair value on a recurring basis
The following table presents the Company’s hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of March 31, 2023:

(In millions)Level 1Level 2Level 3Total
Assets:
Money market funds$3,485 $— $— $3,485 
Foreign currency forward contracts
— 80 — 80 
Interest rate-related derivatives
— — 
Total
$3,485 $81 $— $3,566 
Liabilities:
Cross-currency swap contracts$— 11 $— $11 
Foreign currency forward contracts
— 91 — 91 
Interest rate-related derivatives
— 138 — 138 
DECIEM stock options— — 73 73 
Total
$— $240 $73 $313 
The following table presents the Company’s hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2022:

(In millions)Level 1Level 2Level 3Total
Assets:
Money market funds$961 $— $— $961 
Foreign currency forward contracts
— 191 — 191 
Interest rate-related derivatives
— 24 — 24 
Total
$961 $215 $— $1,176 
Liabilities:
Foreign currency forward contracts
$— $105 $— $105 
Interest rate-related derivatives— 115 — 115 
DECIEM stock options— — 74 74 
Total
$— $220 $74 $294 
Schedule of estimated fair values of financial instruments
The estimated fair values of the Company’s financial instruments are as follows:

March 31, 2023June 30, 2022
(In millions)Carrying
Amount
Fair
Value
Carrying
Amount
Fair
Value
Nonderivatives
Cash and cash equivalents
$5,531 $5,531 $3,957 $3,957 
Current and long-term debt
7,371 7,034 5,412 5,139 
DECIEM stock options73 73 74 74 
Derivatives
Cross-currency swap contracts - liability, net(11)(11)— — 
Foreign currency forward contracts – liability, net(11)(11)86 86 
Interest rate-related derivatives – liability, net(137)(137)(91)(91)
Impairment charges measured at fair value on a nonrecurring basis, classified as Level 3
The following table presents the Company’s impairment charges for the nine months ended March 31, 2023 for certain of its nonfinancial assets measured at fair value on a nonrecurring basis, classified as Level 3, due to a change in circumstances that triggered an interim impairment test during the three months ended December 31, 2022:

(In millions)Impairment chargesDate of Fair Value Measurement
Fair Value(1)
Other intangible assets, net (trademarks)
Dr.Jart+$100 November 30, 2022$330 
Too Faced86 November 30, 2022186 
Smashbox21 December 31, 2022— 
Total$207 $516 
(1)See Note 2 - Goodwill and Other Intangible Assets for discussion of the valuation techniques used to measure fair value, the description of the inputs and information used to develop those inputs.

The following table presents the Company’s impairment charges for the nine months ended March 31, 2022 for certain of its nonfinancial assets measured at fair value on a nonrecurring basis, classified as Level 3, due to a change in circumstances that triggered an interim impairment test:

(In millions)Impairment chargesDate of Fair Value Measurement
Fair Value(1)
Other intangible assets, net (trademarks)
GLAMGLOW$11 March 31, 2022$— 
Dr.Jart+205 February 28, 2022486 
Total216 486 
Total$216 $486 
(1)See Note 2 - Goodwill and Other Intangible Assets for discussion of the valuation techniques used to measure fair value, the description of the inputs and information used to develop those inputs.
Changes in DECEIM stock option liability
Changes in the DECIEM stock option liability for the nine months ended March 31, 2023 are included in Selling, general and administrative expenses in the accompanying consolidated statements of earnings and were as follows:

(In millions)Fair Value
DECIEM stock option liability as of June 30, 2022$74 
Changes in fair value, net of foreign currency remeasurements(1)
(2)
Translation adjustments and other, net
DECIEM stock option liability as of March 31, 2023$73 
(1)Amount includes expense attributable to graded vesting of stock options which is not material for the nine months ended March 31, 2023.